Suchen
Akupunktur aktuell
Wissenschaft - Klinische Studien
no
LOGO
  Wissenschaft,
Praxis,
Fortbildung


E-mail Newsletter
(14-tägig)

So bleiben Sie informiert:
E-mail Adresse eintippen
und ENTER drücken.


omikron publishing
©  Omikron Publishing


Longitudinal study of a cohort receiving acupuncture for HIV-related conditions in Massachusetts

E Sommers, AIDS Care Project, Boston, MA

Objectives: This study describes demographic characteristics, reasons for treatment, and risk factors for disease progression in a cohort of individuals with HIV-related conditions who receive acupuncture treatment.

Methods: A medical record review examined data on health status, quality of life, symptoms, and disease progression in a group of 234 individuals at various stages of HIV-disease.

Results: Of the 234 individuals in the cohort, 204 (87%) were male and ranged in age from 22 to 72 years of age; females comprised 12% of the group and ranged in age from 30 to 54 years of age. Symptoms showing highest prevalence include sinus problems (56%), thrush (24%), and vision abnormalities (20%). Among women, the gynecological conditions that showed highest prevalence included premenstrual syndrome (35%), recurrent yeast infections (31%), and menstrual cramps (31%). Smoking was reported by 63% of the cohort at intake.

Conclusions: Individuals living with HIV/AIDS seek acupuncture treatment for the management of a variety of co-existing conditions. Tobacco smoking emerged as a clinically significant risk factor for decreasing time to disease progression taking age, disease status and co-morbid conditions into account.


Immunomodulation using acupuncture: Assessment using serum immunoglobulin titers

RE Burke1, 2, MB Helbig1, 2, K Suh1, 2, D McDaniel1, 2, D Zamurovic2, HAN El-Fawal1, 3, W Prensky1, 2

1Graduate Program in Acupuncture and Oriental Medicine, Mercy College, Dobbs Ferry, NY, 2Sound Shore Medical Center, New Rochelle, NY, and 3Laboratory of Pharmacology and Toxicology, Mercy College, Dobbs Ferry, NY.

Traditional Chinese Medicine (TCM) has a long history of treating many disorders classified in Western Medicine as having an immunologically-mediated pathogenesis. This includes Type I hypersensitivities, immunoglobulin E (IgE) triggered allergies, such as asthma and allergic rhinitis. Additionally, TCM has long recognized that certain points may have great impact in potentiating immune function. The present preliminary studies were undertaken to investigate (1) the efficacy of acupuncture in ameliorating the symptoms of atopic asthma and allergic rhinitis and in enhancing immune function in normal individuals; (2) whether the efficacy of acupuncture may be associated with modulation of immune activity as indicated by immunoglobulin titers.

In the first study, 11 individuals diagnosed with either asthma (n=5), or allergic rhinitis (n=6) were recruited and treated at Sound Shore Medical Center. A diagnosis of at least 6 months for rhinitis, and a positive skin test for atopy, in asthmatics, were required to participate in the study. Smoking and pregnancy were exclusionary. Participants included 8 females and 3 males, aged 19-65 years. Sera for analysis of IgE titers were collected from participants by venupuncture prior to initiation of treatment and immediately after the last treatment. The acupuncture treatment was twice-weekly, at a minimum interval of 24-hrs, for five weeks, for a total of ten treatments. Acupuncture points common to both populations included: UB12, UB13, UB20, UB23, SP6, and K3. In addition, specific points for asthma or allergic rhinitis were used. Rhinitis patients reported significant (p<0.05) alleviation of allergic attacks and symptoms as measured by a range scale from 1-10 (1=no symptoms; 10=severe). Serum IgE levels, measured using an enzyme-linked immunosorbent assay (ELISA), showed a marked, but not statistically significant, decline between pre-treatment levels and those measured following the last treatment. Similarly, in asthmatics, there was a pronounced decline in serum IgE, which was found to be statistically significant (p<0.05) for those participants identified as yin-deficient (3 of 5). This preliminary study of Type I hypersensitivity patients, although not conclusive, is suggestive of a relationship between acupuncture treatment and a decline in IgE levels which may explain, in part, the success in alleviating allergic symptoms. These studies are currently being expanded to larger cohorts of subjects and will incorporate objective measures of respiratory function.

The second of the studies was undertaken to investigate the effect of stimulating ST36 Zusanli, the point reported to have profound immunomodulating activity. 10 subjects (26-41 years; 4 females and 6 males), were recruited from the professional staff of Sound Shore Medical Center, who had no history of allergies, current infections, drug use, or other acupuncture treatments within 30 days of study initiation. Subjects were randomly assigned to two groups, those that would receive acupuncture, and those treated with a placebo needle (Streitberger and Kleinhenz, 1998, The Lancet, 352:364-365). Sera for analysis of IgG and IgM were collected 9 and 2 days prior to a single 25-min treatment, and 24 and 48 hrs post-treatment. In addition, complete blood counts (CBC), including differentials of subjects' blood were performed at these time periods. Lymphocyte counts were elevated at 48 hrs in 4 of 6 subjects where Zusanli was stimulated, whereas monocyte counts were significantly higher (p<0.02) compared to pre-treatment. There were no significant changes in cell counts of subjects treated with the placebo needle. IgM, the immunoglobulin associated with primary challenge, significantly increased (p<0.05) at 24 hrs following acupuncture treatment, but not after placebo treatment. IgG levels did not change in either group. This preliminary study suggests that stimulation of zusanli may potentiate acquired specific immune parameters and demonstrates the potential of acupuncture as an effective modality for immunomodulation.

(Supported in part by NIH HD35965 at Mercy College).